Cystic vs. Solid Thyroid Nodules: How RFA Approach Differs

Cystic vs. Solid Thyroid Nodules: How RFA Approach Differs

TL;DR: RFA planning for thyroid nodules depends heavily on whether the lesion is cystic, solid, or mixed. The blog explains that composition affects treatment sequencing, energy delivery, expected shrinkage, and safety measures, so clinicians should tailor technique to the nodule rather than use the same approach for every case.

  • Cystic thyroid nodules often begin with aspiration to remove fluid, reduce pressure, and improve visualization of the remaining treatment target.
  • Purely cystic or largely cystic nodules may be better suited to ethanol ablation, with RFA used when a lesion recurs or retains a solid component.
  • During RFA of cystic nodules, treatment focuses on the viable lining and residual solid tissue, not the drained cavity itself.
  • Solid thyroid nodules require a moving shot technique that treats the lesion unit by unit to avoid undertreated margins and later regrowth.
  • Larger solid nodules may need longer or repeat sessions, and hydrodissection can improve safety and comfort.


When evaluating cystic vs solid thyroid nodules, composition is key to creating a safe and effective ablation plan. Ultrasound helps classify nodules on thyroid as fluid-filled, tissue-dominant, or mixed.

A cystic thyroid nodule usually contains mostly fluid, while a solid thyroid nodule contains denser tissue that requires direct thermal treatment. That distinction affects targeting and expected shrinkage. It can also help clinicians decide whether another technique should be considered before or along with RFA.

In this blog, we’ll expand on how nodule composition influences treatment planning, and which RFA approach is most appropriate for each type.

Cystic Thyroid Nodule Treatment Planning Before RFA

For a cystic thyroid nodule, treatment typically starts with aspiration. Draining fluid reduces pressure and, ultimately, improves visualization, which helps define the tissue that still needs treatment.

Purely cystic nodules, or nodules with more than 20% cystic content, are generally better suited to ethanol ablation. RFA may still play an important role when the lesion recurs or includes a solid component.

Cystic Nodule Thyroid Gland Approach During RFA

When RFA is used for a cystic nodule thyroid gland, the target is the viable lining and any remaining solid tissue.

A recent prospective study of benign cystic and predominantly cystic thyroid nodules used aspiration followed by electrode placement through a trans-isthmic approach and moving-shot ablation of the residual target. At 12 months, volume reduction remained above 80%, with stronger reduction in purely cystic nodules than in predominantly cystic lesions. No major complications were reported.

Solid Nodules in the Thyroid Gland: RFA Technique

A solid thyroid nodule requires a more tissue-focused strategy. The moving shot technique is the standard method for thyroid RFA.

During the moving shot technique, the nodule is divided into small ablation units. The electrode is advanced or withdrawn unit by unit so energy can be delivered evenly across the lesion. This matters in solid nodules because undertreated peripheral tissue can remain viable and contribute to regrowth on follow-up.

Solid Thyroid Nodule Outcomes, Safety, and Patient Expectations

Procedural planning also differs for a solid thyroid nodule. Larger nodules often need longer treatment time. Nodule volumes above about 20 to 30 mL are more likely to require multiple sessions.

The hydrodissection technique may be used to create space between the thyroid capsule and nearby critical structures. Use of the technique lowers the risk of thermal injury and can also help with pain control during treatment.

In practice, cystic lesions may show faster relief after drainage, while solid nodules usually shrink more gradually over the months that follow.

Cystic vs Solid Thyroid Nodules: What Clinicians Should Keep in Mind

Matching RFA technique to nodule composition helps improve effectiveness and supports safer treatment planning. Ultimately, the composition of nodules should guide whether the clinician starts with aspiration. If RFA is the preferred treatment, it impacts how energy is delivered, how margins are planned, and what outcome timeline to expect.

Is RFA the right treatment option for your patients? Reach out to speak with a specialist who can answer your questions and walk you through next steps.

Contents

Learn More About STARMED Technology

Do you have more questions to ask about ablation? Our team is happy to help. Contact us to learn more about implementing RFA in your practice.

Stay informed with STARMED Technology

Download the Thyroid RFA clinical data sheet

See how safe and effective STARMED’s industry-leading equipment is in practice.

By submitting this form, you consent to receive marketing emails from STARMED America at the email provided. You can unsubscribe at any time. Please see our privacy policy for more information.